Prestige Consumer Healthcare (PBH) Common Equity (2011 - 2026)

Prestige Consumer Healthcare has reported Common Equity for 16 years, with the latest figure at $1.9 billion in Q1 2026.

• On a quarterly basis, Common Equity rose 2.87% year-over-year to $1.9 billion in Q1 2026; TTM through Mar 2026 was $1.9 billion, a 2.87% increase from a year earlier, with the FY2026 full-year figure at $1.9 billion, up 2.87% from the prior year.
• Common Equity was $1.9 billion for Q1 2026 at Prestige Consumer Healthcare, up from $1.8 billion in the prior quarter.
• The five-year high for Common Equity was $1.9 billion in Q1 2026, with the low at $1.4 billion in Q1 2023.
• Average Common Equity over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Common Equity gained 16.15% in 2022, then slipped 8.27% in 2023.
• Over 5 years, Common Equity stood at $1.7 billion in 2022, then declined by 5.12% to $1.6 billion in 2023, then rose by 11.74% to $1.8 billion in 2024, then advanced by 2.29% to $1.8 billion in 2025, then advanced by 3.17% to $1.9 billion in 2026.
• The last three Common Equity figures came in at $1.9 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.